When you need immediate vascular access in pediatric patients, you can be confident that the NIO Pediatric™ is complete and ready to use — no batteries, assembly, or extra parts required. Its provider-friendly design features a removable red spacer, which adjusts the penetration depth from 14mm to 18mm, accommodating pediatric patients 3–12 years old. With redundant safety features and built-in locating arrows that aid insertion site identification, you can trust the NIO Pediatric™ to deliver safe, rapid IO access.
Features:
- Built-in unique locating arrows aid with insertion site identification, simplifying the procedure for providers.
- Preset needle penetration depth (14mm for 3–9 y/o; 18mm for 9–12 y/o) simplifying the procedure and helping to prevent over-penetration.
- Automatic device, no batteries, assembly, or extra parts required.
- Pocket-sized and lightweight
- Sterile and single-use—eliminates the risk of cross-contamination.
- Self-contained device with no exposed needle
- 5-year shelf life (at room temp.)
- Legal Manufacturer: WaisMed Ltd
- PN: NIO-P
- Needle gauge: 18 Gauge.
- 3–9 y/o penetration depth: 14mm
- 9–12 y/o penetration depth: 18mm
- Device dimensions: 5.85in x 2.24in x 1.06in (14.86cmX5.7cmX2.7cm)
- Package dimensions: 7.64in x 3.3in x 1.3in (19.4cm x 8.4cm x 3.3cm)
- Weight: 4.48oz (127g)
- Shelf life: 5 years at room temperature
Clinically Proven Success
Safe on the bone.
The NIO has proven to be safe on the bone and resulted in zero incidents of bone fracture as observed by post-insertion x-rays.
Easily tolerates common user errors.
A recent study evaluated common user errors related to needle placement and found that even when placed up to 5cm from the correct insertion site, the NIO maintained an 85% success rate.
First attempt success rates as high as 98%.
Initial studies demonstrated an overall average success rate of 91.3% for the proximal tibia and 93.1% for the humeral head. The New York Institute of Osteopathic Medicine conducted an additional study which established a proximal tibia success rate of over 98%1
